Furthermore, with the increase in MCL dose, the levels of IL-1β and IL-18 showed a decreasing trend, indicating that MCL dose-dependently reduces serum IL-1β and IL-18 levels in OVA-sensitised asthmatic mice.
← all excerpts
Protective effect of micheliolide against inflammation and oxidative stress in asthma through the MAPK/NF-κB signalling pathway.
1
—
—